Thanks JandJ. I too am confident they are working on it based on information from management. It’s challenging to resolve it for assays from phase 1 that were already in train. For phase 2 I understand they are using a different approach to what was recommended for phase 1. However, the proof will be in the timely delivery of assay results going forward.
Regarding the weather. My understanding is they packed up before the weather turned and all phase 2 assays are at the lab.
The only other box to tick for me is clarity around market access/delivery. I am very comfortable with the economics and production simplicity but cannot see a path to market yet. Who is going to buy the concentrate? I’m not inferring it’s not saleable, I just want to understand this leg better.
Ann: Sandy Mitchell Stage 2 Drill Program Successfully Completed, page-7
Add AHK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.020(9.52%) |
Mkt cap ! $12.75M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.0¢ | 22.0¢ | $9.497K | 41.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 7008 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| AHK (ASX) Chart |